D-Arginine action against neurotoxicity induced by glucocorticoids in the brain

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 6, 2011, Pages 1353-1362

  Griselda, Canteros Maria ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Cationic amino acid transporters; D Arginine; Glucocorticoids; Hippocampus; L Arginine; L Arginine availability; Neuroprotection; Reactive oxygen species

Indexed keywords

ARGININE; DEXTRO ARGININE; GLUCOCORTICOID;

AMINO ACID BLOOD LEVEL; BRAIN TOXICITY; CATABOLISM; CENTRAL NERVOUS SYSTEM; CHRONIC STRESS; DRUG MECHANISM; HIPPOCAMPUS; HORMONE ACTION; HUMAN; LIFE STRESS; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARGININE; BRAIN; GLUCOCORTICOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; REACTIVE OXYGEN SPECIES;

EID: 79954590712     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.02.009     Document Type: Review

References (188)

1. 2+ concentration in gerbil hippocampus. J. Cereb. Blood Flow Metab. 1998, 18:274-280.
2. Ago Y., Arikawa S., Yata M., Yano K., Abe M., Takuma K., Matsuda T. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity. Synapse 2009, 63:7-14.
3. Albina J.E., Mills C.D., Barbul A., Thirkill C.E., Henry W.L., Mastrofrancesco B., Caldwell M.D. Arginine metabolism in wounds. Am. J. Physiol. 1988, 254:E459-E467.
4. Almeida A., Almeida J., Bolanos J.P., Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15294-15299.
5. Almeida A., Bolanos J.P. A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J. Neurochem. 2001, 77:676-690.
6. Aoki E., Semba R., Mikoshiba K., Kashiwamata S. Predominant localization in glial cells of free L-arginine. Immunocytochemical evidence. Brain Res. 1991, 547:190-192.
7. Aulak K.S., Mishra R., Zhou L., Hyatt S.L., de Jonge W., Lamers W., Snider M., Hatzoglou M. Post-transcriptional regulation of the arginine transporter Cat-1 by amino acid availability. J. Biol. Chem. 1999, 274:30424-30432.
8. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
9. Aziz N.A., Pijl H., Frolich M., van der Graaf A.W., Roelfsema F., Roos R.A. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J. Clin. Endocrinol. Metab. 2009, 94:1223-1228.
10. Bae S.Y., Xu Q., Hutchinson D., Colton C.A. Y+ and y+ L arginine transporters in neuronal cells expressing tyrosine hydroxylase. Biochim. Biophys. Acta 2005, 1745:65-73.
11. Baker D.H., Boebel K.P. Utilization of the D-isomers of arginine and histidine by chicks and rats. J. Anim. Sci. 1981, 53:125-129.
12. Baltrons M.A., Agullo L., Garcia A. Dexamethasone up-regulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J. Neurochem. 1995, 64:447-450.
13. Bennett A.O.M. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression. Aust. N. Z. J. Psychiatry 2008, 42:995-1002.
14. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272:20313-20316.
15. Bhargava H.N., Bian J.T., Kumar S. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. J. Pharmacol. Exp. Ther. 1997, 281:707-712.
16. Bjelakovic G., Beninati S., Pavlovic D., Kocic G., Jevtovic T., Kamenov B., Saranac L.J., Bjelakovic B., Stojanovic I., Basic J. Glucocorticoids and oxidative stress. J. Basic Clin. Physiol. Pharmacol. 2007, 18:115-127.
17. Blau N., Thony B. Tetrahydrobiopterin in biomedical research. J. Inherit. Metab. Dis. 2009, 32:1-2.
18. Bocheva A. Effect of D-arginine on antinociception induced by kyotorphin, Tyr-cav, L-cav and Tyr(Cl2)-cav in rats. Methods Find. Exp. Clin. Pharmacol. 2004, 26:335-338.
19. Boller T., Durr M., Wiemken A. Characterization of a specific transport system for arginine in isolated yeast vacuoles. Eur. J. Biochem. 1975, 54:81-91.
20. Braissant O., Gotoh T., Loup M., Mori M., Bachmann C. Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain. Brain Res. Mol. Brain Res. 2001, 91:189-195.
21. Brenneman D.E., Spong C.Y., Hauser J.M., Abebe D., Pinhasov A., Golian T., Gozes I. Protective peptides that are orally active and mechanistically nonchiral. J. Pharmacol. Exp. Ther. 2004, 309:1190-1197.
22. Brown G.C. Nitric oxide and neuronal death. Nitric Oxide 2010, 23:153-165.
23. Buniatian H.C., Davtian M.A. Urea synthesis in brain. J. Neurochem. 1966, 13:743-753.
24. Burnet P.W., Mefford I.N., Smith C.C., Gold P.W., Sternberg E.M. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat. J. Neurochem. 1992, 59:1062-1070.
25. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 2001, 7:548-554.
26. Calabrese V., Boyd-Kimball D., Scapagnini G., Butterfield D.A. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo 2004, 18:245-267.
27. Calabrese V., Scapagnini G., Ravagna A., Colombrita C., Spadaro F., Butterfield D.A., Giuffrida Stella A.M. Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech. Ageing Dev. 2004, 125:325-335.
28. Canteros, G., 1999. D-arginine - a functional antagonist of glucocorticoid actions in the hippocampus. Ernst-und-Berta-Scharrer-Preis (Supplementary information).
29. Canteros G., Rettori V., Franchi A., Genaro A., Cebral E., Faletti A., Gimeno M., McCann S.M. Ethanol inhibits luteinizing hormone-releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:3416-3420.
30. Canteros G., Rettori V., Genaro A., Suburo A., Gimeno M., McCann S.M. Nitric oxide synthase content of hypothalamic explants: increase by norepinephrine and inactivated by NO and cGMP. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:4246-4250.
31. Capasso A. Glucocorticoids involvement in the control of CNS excitability. Recent Pat. CNS Drug Discov. 2007, 2:155-165.
32. Castellano M.A., Rojas-Diaz D., Martin F., Quintero M., Alonso J., Navarro E., Gonzalez-Mora J.L. Opposite effects of low and high doses of arginine on glutamate-induced nitric oxide formation in rat substantia nigra. Neurosci. Lett. 2001, 314:127-130.
33. Cidlowski J.A., King K.L., Evans-Storms R.B., Montague J.W., Bortner C.D., Hughes F.M. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog. Horm. Res. 1996, 51:457-490. discussion 490-451.
34. Closs E.I., Albritton L.M., Kim J.W., Cunningham J.M. Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J. Biol. Chem. 1993, 268:7538-7544.
35. Closs E.I., Graf P. Cationic amino acid transporters (CATs). Targets for the manipulation of NO-synthase activity?. Pharm. Biotechnol. 1999, 12:229-249.
36. Conde M.V., Marco E.J., Fraile M.L., Benito J.M., Moreno M.J., Sanz M.L., Lopez de Pablo A.L. Different influence of endothelium in the mechanical responses of human and cat isolated cerebral arteries to several agents. J. Pharm. Pharmacol. 1991, 43:255-261.
37. Cortes-Rojo C., Clemente-Guerrero M., Saavedra-Molina A. Effects of D-amino acids on lipoperoxidation in rat liver and kidney mitochondria. Amino Acids 2007, 32:31-37.
38. Christensen H.N., Albritton L.M., Kakuda D.K., MacLeod C.L. Gene-product designations for amino acid transporters. J. Exp. Biol. 1994, 196:51-57.
39. Christensen H.N., Antonioli J.A. Cationic amino acid transport in the rabbit reticulocyte. Na+-dependent inhibition of Na+-independent transport. J. Biol. Chem. 1969, 244:1497-1504.
40. + in transport. Biochim. Biophys. Acta 1969, 193:228-230.
41. Dallinger S., Sieder A., Strametz J., Bayerle-Eder M., Wolzt M., Schmetterer L. Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1106-E1111.
42. De Kloet E.R., McEwen B.S. Differences between cytosol receptor complexes with corticosterone and dexamethasone in hippocampal tissue from rat brain. Biochim. Biophys. Acta 1976, 421:124-132.
43. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
44. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Front. Neuroendocrinol. 2009, 30:358-370.
45. Deutsch S.I., Rosse R.B., Paul S.M., Tomasino V., Koetzner L., Morn C.B., Mastropaolo J. 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology 1996, 15:37-43.
46. Deves R., Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 1998, 78:487-545.
47. Di S., Maxson M.M., Franco A., Tasker J.G. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J. Neurosci. 2009, 29:393-401.
48. Do K.Q., Grima G., Benz B., Salt T.E. Glial-neuronal transfer of arginine and S-nitrosothiols in nitric oxide transmission. Ann. N. Y. Acad. Sci. 2002, 962:81-92.
49. Du J., Wang Y., Hunter R., Wei Y., Blumenthal R., Falke C., Khairova R., Zhou R., Yuan P., Machado-Vieira R., McEwen B.S., Manji H.K. Dynamic regulation of mitochondrial function by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3543-3548.
50. Durante W. Regulation of L-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem. Biophys. 2001, 35:19-34.
51. Durante W., Liao L., Schafer A.I. Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am. J. Physiol. 1995, 268:H1158-H1164.
52. Elliott E.M., Sapolsky R.M. Corticosterone impairs hippocampal neuronal calcium regulation - possible mediating mechanisms. Brain Res. 1993, 602:84-90.
53. Epel E.S. Psychological and metabolic stress: a recipe for accelerated cellular aging?. Hormones (Athens) 2009, 8:7-22.
54. Fernandez-Checa J.C., Fernandez A., Morales A., Mari M., Garcia-Ruiz C., Colell A. Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models. CNS Neurol. Disord. Drug Targets 2010, 9:439-454.
55. Flodstrom M., Niemann A., Bedoya F.J., Morris S.M., Eizirik D.L. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines. Endocrinology 1995, 136:3200-3206.
56. Flynn N.E., Wu G. Glucocorticoids play an important role in mediating the enhanced metabolism of arginine and glutamine in enterocytes of postweaning pigs. J. Nutr. 1997, 127:732-737.
57. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 1989, 3:2007-2018.
58. Garcia M., Moran A., Luisa Martin M., Barthelmebs M., San Roman L. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. Eur. J. Pharmacol. 2006, 537:126-134.
59. Gargiulo Monachelli G., Meyer M., Rodriguez G.E., Garay L.I., Sica R.E., De Nicola A.F., Gonzalez Deniselle M.C. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol. Scand. 2011, 123:60-67.
60. Gella A., Durany N. Oxidative stress in Alzheimer disease. Cell Adh. Migr. 2009, 3:88-93.
61. Gensert J.M., Ratan R.R. The metabolic coupling of arginine metabolism to nitric oxide generation by astrocytes. Antioxid. Redox Signal. 2006, 8:919-928.
62. Gessi S., Merighi S., Borea P.A. Glucocorticoid's pharmacology: past present and future. Curr. Pharm. Des. 2010, 16:3540-3553. (Epub 20/10/28).
63. Gold P.W., Gabry K.E., Yasuda M.R., Chrousos G.P. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol. Metab. Clin. North Am. 2002, 31:37-62. vi.
64. Goodman Y., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 1994, 128:1-12.
65. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiatry 1999, 46:1472-1479.
66. Gozes I., Divinski I., Piltzer I. NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). BMC Neurosci. 2008, 9(Suppl. 3):S3.
67. Grima G., Cuenod M., Pfeiffer S., Mayer B., Do K.Q. Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis: involvement of a glial-neuronal arginine transfer. J. Neurochem. 1998, 71:2139-2144.
68. Grosvenor W., Kaulin Y., Spielman A.I., Bayley D.L., Kalinoski D.L., Teeter J.H., Brand J.G. Biochemical enrichment and biophysical characterization of a taste receptor for L-arginine from the catfish, Ictalurus puntatus. BMC Neurosci. 2004, 5:25.
69. Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol. Cell. Biol. 2003, 23:4598-4610.
70. Harrison J.F., Hollensworth S.B., Spitz D.R., Copeland W.C., Wilson G.L., LeDoux S.P. Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance. Nucleic Acids Res. 2005, 33:4660-4671.
71. Hasson J., Weidenfeld J., Mizrachi-Kol R., Ben-Hur T., Ovadia H. The effect of herpes simplex virus-1 on nitric oxide synthase in the rat brain: the role of glucocorticoids. Neuroimmunomodulation 2011, 18:111-116.
72. Hattori Y., Campbell E.B., Gross S.S. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis. J. Biol. Chem. 1994, 269:9405-9408.
73. Hatzoglou M., Fernandez J., Yaman I., Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu. Rev. Nutr. 2004, 24:377-399.
74. Haynes L.E., Griffiths M.R., Hyde R.E., Barber D.J., Mitchell I.J. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001, 104:57-69.
75. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997, 20:78-84.
76. Hitoshi S., Maruta N., Higashi M., Kumar A., Kato N., Ikenaka K. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J. Neurosci. Res. 2007, 85:3574-3585.
77. Hu W., Zhang M., Czeh B., Flugge G., Zhang W. Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology 2010, 35:1693-1707.
78. Huang Y., Kang B.N., Tian J., Liu Y., Luo H.R., Hester L., Snyder S.H. The cationic amino acid transporters CAT1 and CAT3 mediate NMDA receptor activation-dependent changes in elaboration of neuronal processes via the mammalian target of rapamycin mTOR pathway. J. Neurosci. 2007, 27:449-458.
79. Ignarro L.J., Buga G.M., Wei L.H., Bauer P.M., Wu G., del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4202-4208.
80. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:9265-9269.
81. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 2005, 72:1290-1296.
82. Ishii M., Shimizu S., Nagai T., Shiota K., Kiuchi Y., Yamamoto T. Stimulation of tetrahydrobiopterin synthesis induced by insulin: possible involvement of phosphatidylinositol 3-kinase. Int. J. Biochem. Cell Biol. 2001, 33:65-73.
83. Ito K., Groudine M. A new member of the cationic amino acid transporter family is preferentially expressed in adult mouse brain. J. Biol. Chem. 1997, 272:26780-26786.
84. Jackson M.J., Zielke H.R., Zielke C.L. Induction of astrocyte argininosuccinate synthetase and argininosuccinate lyase by dibutyryl cyclic AMP and dexamethasone. Neurochem. Res. 1996, 21:1161-1165.
85. Jhala S.S., Hazell A.S. Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism. Neurochem. Int. 2011, 58:248-260. Dec 3 [Epub ahead of print].
86. Kakuda D.K., Finley K.D., Maruyama M., MacLeod C.L. Stress differentially induces cationic amino acid transporter gene expression. Biochim. Biophys. Acta 1998, 1414:75-84.
87. Kakuda D.K., Sweet M.J., Mac Leod C.L., Hume D.A., Markovich D. CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. Biochem. J. 1999, 340(Pt 2):549-553.
88. Kawabata A., Nishimura Y., Takagi H. L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia. Br. J. Pharmacol. 1992, 107:1096-1101.
89. Kawashima H., Numakawa T., Kumamaru E., Adachi N., Mizuno H., Ninomiya M., Kunugi H., Hashido K. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience 2010, 165:1301-1311.
90. Kemp J.W., Woodbury D.M. Synthesis of urea-cycle intermediates from citrulline in brain. Biochim. Biophys. Acta 1965, 111:23-31.
91. Khovryakov A.V., Podrezova E.P., Kruglyakov P.P., Shikhanov N.P., Balykova M.N., Semibratova N.V., Sosunov A.A., McKhann G., Airapetyants M.G. Involvement of the NO synthase system in stress-mediated brain reactions. Neurosci. Behav. Physiol. 2010, 40:333-337.
92. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal 2010, 3:ra8.
93. Korhonen R., Lahti A., Hamalainen M., Kankaanranta H., Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 2002, 62:698-704.
94. Krebs H.A. Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues. Biochem. J. 1935, 29:1951-1969.
95. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
96. Kumazawa T., Brand J.G., Teeter J.H. Amino acid-activated channels in the catfish taste system. Biophys. J. 1998, 75:2757-2766.
97. Kurz D.J., Decary S., Hong Y., Trivier E., Akhmedov A., Erusalimsky J.D. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J. Cell Sci. 2004, 117:2417-2426.
98. Kwon M.S., Seo Y.J., Choi S.M., Choi H.W., Jung J.S., Park S.H., Suh H.W. The differential effects of single or repeated restraint stress on kainic acid-induced neuronal death in the hippocampal CA3 region: the role of glucocorticoid and various signal molecules. J. Neurochem. 2007, 103:1530-1541.
99. Lee M., Dai J.K., Meltzer J.H. Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration. Psychiatry Res. 2011, 185:328-333. [Epub ahead of print].
100. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 2002, 33:1085-1092.
101. Leonard B.E. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 2005, 20(Suppl. 3):S302-S306.
102. Little J.A., Hauser K.P., Martyr S.E., Harris A., Maric I., Morris C.R., Suh J.H., Taylor J., Castro O., Machado R., Kato G., Gladwin M.T. Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy. Eur. J. Haematol. 2009, 82:315-321.
103. Marchetti B., Serra P.A., Tirolo C., L'Episcopo F., Caniglia S., Gennuso F., Testa N., Miele E., Desole S., Barden N., Morale M.C. Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Res. Brain Res. Rev. 2005, 48:302-321.
104. Marzo I., Brenner C., Zamzami N., Susin S.A., Beutner G., Brdiczka D., Remy R., Xie Z.H., Reed J.C., Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 1998, 187:1261-1271.
105. McCarty M.F., Barroso-Aranda J., Contreras F. Oxidative stress therapy for solid tumors - a proposal. Med. Hypotheses 2010, 74:1052-1054.
106. McConkey D.J., Orrenius S. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 1997, 239:357-366.
107. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
108. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur. J. Pharmacol. 2008, 583:174-185.
109. McEwen B.S., Gianaros P.J. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann. N. Y. Acad. Sci. 2010, 1186:190-222.
110. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995, 5:205-216.
111. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220:911-912.
112. McIntosh L.J., Cortopassi K.M., Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: kainic acid studies. Brain Res. 1998, 791:215-222.
113. McIntosh L.J., Hong K.E., Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res. 1998, 791:209-214.
114. McIntosh L.J., Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp. Neurol. 1996, 141:201-206.
115. McIntosh L.J., Sapolsky R.M. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 1996, 17:873-882.
116. McVeigh G.E., Allen P.B., Morgan D.R., Hanratty C.G., Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin. Sci. (Lond.) 2001, 100:387-393.
117. Melisi D., Secondo A., Montoro P., Piacente S., Rimoli M.G., Minale M., de Caprariis P., Annunziato L. Galactosyl derivatives of L-arginine and D-arginine: synthesis, stability, cell permeation, and nitric oxide production in pituitary GH3 cells. J. Med. Chem. 2006, 49:4826-4833.
118. Melov S. Modeling mitochondrial function in aging neurons. Trends Neurosci. 2004, 27:601-606.
119. Metz G.A. Stress as a modulator of motor system function and pathology. Rev. Neurosci. 2007, 18:209-222.
120. Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J. Nutr. 2007, 137:1616S-1620S.
121. Mori M., Gotoh T. Arginine metabolic enzymes, nitric oxide and infection. J. Nutr. 2004, 134:2820S-2825S. discussion 2853S.
122. Morris S.M. Regulation of enzymes of urea and arginine synthesis. Annu. Rev. Nutr. 1992, 12:81-101.
123. Munck A., Guyre P.M. Glucocorticoid physiology, pharmacology and stress. Adv. Exp. Med. Biol. 1986, 196:81-96.
124. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 1986, 78:1-5.
125. Nader N., Ng S.S., Lambrou G.I., Pervanidou P., Wang Y., Chrousos G.P., Kino T. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol. Endocrinol. 2010, 24:1748-1764. Epub Date 2010/1707/1728.
126. Nakamura H., Saheki T., Nakagawa S. Differential cellular localization of enzymes of L-arginine metabolism in the rat brain. Brain Res. 1990, 530:108-112.
127. Navarro E., Alonso S.J., Martin F.A., Castellano M.A. Toxicological and pharmacological effects of D-arginine. Basic Clin. Pharmacol. Toxicol. 2005, 97:149-154.
128. Nelson D.H. Regulation of glucocorticoid release. Am. J. Med. 1972, 53:590-594.
129. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
130. Noguchi K.K., Walls K.C., Wozniak D.F., Olney J.W., Roth K.A., Farber N.B. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ. 2008, 15:1582-1592.
131. Novaro V., Rettori V., Gonzalez E.T., Jawerbaum A., Faletti A., Canteros G., de Gimeno M.A. Interaction between uterine PGE and PGF2 alpha production and the nitridergic system during embryonic implantation in the rat. Prostaglandins 1996, 51:363-376.
132. Pennisi P., D'Alcamo M.A., Leonetti C., Clementi A., Cutuli V.M., Riccobene S., Parisi N., Fiore C.E. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model. J. Bone Miner. Metab. 2005, 23:134-139.
133. Pinnock S.B., Balendra R., Chan M., Hunt L.T., Turner-Stokes T., Herbert J. Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology 2007, 32:493-504.
134. Pow D.V. Immunocytochemical evidence for a glial localisation of arginine, and a neuronal localisation of citrulline in the rat neurohypophysis: implications for nitrergic transmission. Neurosci. Lett. 1994, 181:141-144.
135. Pow D.V., Crook D.K. Immunocytochemical analysis of the transport of arginine analogues into nitrergic neurons and other cells in the retina and pituitary. Cell Tissue Res. 1997, 290:501-514.
136. Prager E.M., Johnson L.R. Stress at the synapse: signal transduction mechanisms of adrenal steroids at neuronal membranes. Sci. Signal. 2009, 2:re5.
137. Raadsheer F.C., Sluiter A.A., Ravid R., Tilders F.J., Swaab D.F. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res. 1993, 615:50-62.
138. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 1995, 152:1372-1376.
139. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 2000, 48:766-777.
140. Ratner S., Morell H., Carvalho E. Enzymes of arginine metabolism in brain. Arch. Biochem. Biophys. 1960, 91:280-289.
141. Reagan L.P., McEwen B.S. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J. Chem. Neuroanat. 1997, 13:149-167.
142. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
143. Roberts R.A., Laskin D.L., Smith C.V., Robertson F.M., Allen E.M., Doorn J.A., Slikker W. Nitrative and oxidative stress in toxicology and disease. Toxicol. Sci. 2009, 112:4-16.
144. Romeo R.D., Waters E.M., McEwen B.S. Steroid-induced hippocampal synaptic plasticity: sex differences and similarities. Neuron Glia Biol. 2004, 1:219-229.
145. Rothman S.M., Mattson M.P. Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med. 2010, 12:56-70.
146. Salem N.A., Salem E.A., Maarouf A.M., Kamel M., Elgalaly H., Radwan M., El-Dayem W.A., Eladl M. Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats. Ren. Fail. 2010, 32:959-968.
147. Salvadore G., Quiroz J.A., Machado-Vieira R., Henter I.D., Manji H.K., Zarate C.A. The neurobiology of the switch process in bipolar disorder: a review. J. Clin. Psychiatry 2010, 71:1488-1501.
148. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 1985, 5:1228-1232.
149. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996, 1:1-19.
150. Sapolsky R.M., Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985, 229:1397-1400.
151. Sasaki T., Senda M., Kim S., Kojima S., Kubodera A. Age-related changes of glutathione content, glucose transport and metabolism, and mitochondrial electron transfer function in mouse brain. Nucl. Med. Biol. 2001, 28:25-31.
152. Sayre L.M., Moreira P.I., Smith M.A., Perry G. Metal ions and oxidative protein modification in neurological disease. Ann. Ist. Super. Sanita 2005, 41:143-164.
153. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 2008, 21:172-188.
154. Schmidlin A., Fischer S., Wiesinger H. Transport of L-citrulline in neural cell cultures. Dev. Neurosci. 2000, 22:393-398.
155. Schmidlin A., Wiesinger H. Transport of L-arginine in cultured glial cells. Glia 1994, 11:262-268.
156. Schmidlin A., Wiesinger H. Stimulation of arginine transport and nitric oxide production by lipopolysaccharide is mediated by different signaling pathways in astrocytes. J. Neurochem. 1995, 65:590-594.
157. Shi W., Meininger C.J., Haynes T.E., Hatakeyama K., Wu G. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell. Biochem. Biophys. 2004, 41:415-434.
158. Shiryaev S.A., Ratnikov B.I., Chekanov A.V., Sikora S., Rozanov D.V., Godzik A., Wang J., Smith J.W., Huang Z., Lindberg I., Samuel M.A., Diamond M.S., Strongin A.Y. Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem. J. 2006, 393:503-511.
159. Simmons W.W., Ungureanu-Longrois D., Smith G.K., Smith T.W., Kelly R.A. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J. Biol. Chem. 1996, 271:23928-23937.
160. Sitdikova G.F., Yakovlev A.V., Zefirov A.L., Arkhipova O.V. The effects of L- and D-stereoisomers on the transmitter secretion and ionic currents in the motor nerve ending. Dokl. Biol. Sci. 2003, 393:523-526.
161. Skimming J.W., Nasiroglu O., Huang C.J., Wood C.E., Stevens B.R., Haque I.U., Scumpia P.O., Sarcia P.J. Dexamethasone suppresses iNOS yet induces GTPCH and CAT-2 mRNA expression in rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L484-L491.
162. Slotkin T.A., Kreider M.L., Tate C.A., Seidler F.J. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. Neuropsychopharmacology 2006, 31:904-911.
163. Stein-Behrens B., Mattson M.P., Chang I., Yeh M., Sapolsky R. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 1994, 14:5373-5380.
164. Stein-Behrens B.A., Elliott E.M., Miller C.A., Schilling J.W., Newcombe R., Sapolsky R.M. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J. Neurochem. 1992, 58:1730-1735.
165. Suzuki E., Shintani F., Nakaki T., Nagata K., Yamazoe Y., Fujita N., Asai M., Kanba S. Dexamethasone and nitric oxide synthase gene expression in brain. J. Psychiatry Neurosci. 1997, 22:105-110.
166. Takao K., Nagatani T., Kitamura Y., Yamawaki S. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Eur. J. Pharmacol. 1997, 333:123-128.
167. Tan B., Yin Y., Liu Z., Li X., Xu H., Kong X., Huang R., Tang W., Shinzato I., Smith S.B., Wu G. Dietary L-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs. Amino Acids 2008, 37:323-331.
168. Tomomura M., Tomomura A., Dewan M.A., Saheki T. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action. FEBS Lett. 1996, 399:310-312.
169. Ularntinon S., Tzuang D., Dahl G., Shaw R.J. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 2010, 125:e1241-e1245.
170. Ulbright C., Snodgrass P.J. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms. Arch. Biochem. Biophys. 1993, 301:237-243.
171. Visek W.J. Arginine and disease states. J. Nutr. 1985, 115:532-541.
172. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 2008, 4:189-216.
173. Weidenfeld J., Feldman S., Itzik A., Van de Kar L.D., Newman M.E. Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and corticosterone secretion in the rat. Brain Res. 2002, 941:113-117.
174. Werner E.R., Gorren A.C., Heller R., Werner-Felmayer G., Mayer B. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp. Biol. Med. (Maywood) 2003, 228:1291-1302.
175. Wong M.L., Rettori V., al-Shekhlee A., Bongiorno P.B., Canteros G., McCann S.M., Gold P.W., Licinio J. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 1996, 2:581-584.
176. Wu G. Intestinal mucosal amino acid catabolism. J. Nutr. 1998, 128:1249-1252.
177. Wu G., Bazer F.W., Cudd T.A., Jobgen W.S., Kim S.W., Lassala A., Li P., Matis J.H., Meininger C.J., Spencer T.E. Pharmacokinetics and safety of arginine supplementation in animals. J. Nutr. 2007, 137:1673S-1680S.
178. Wu G., Meininger C.J. Arginine nutrition and cardiovascular function. J. Nutr. 2000, 130:2626-2629.
179. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998, 336(Pt 1):1-17.
180. Xiao L., Feng C., Chen Y. Glucocorticoid rapidly enhances NMDA-evoked neurotoxicity by attenuating the NR2A-containing NMDA receptor-mediated ERK1/2 activation. Mol. Endocrinol. 2010, 24:497-510.
181. Yao X., Rarey K.E. Detection and regulation of Cu/Zn-SOD and Mn-SOD in rat cochlear tissues. Hear Res. 1996, 96:199-203.
182. You J.M., Yun S.J., Nam K.N., Kang C., Won R., Lee E.H. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can. J. Physiol. Pharmacol. 2009, 87:440-447.
183. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.
184. Zafir A., Banu N. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 2009, 12:167-177.
185. Zakian V.A. Telomeres: beginning to understand the end. Science 1995, 270:1601-1607.
186. Zamzami N., Brenner C., Marzo I., Susin S.A., Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 1998, 16:2265-2282.
187. Zhu X., Herrera G., Ochoa J.B. Immunosupression and infection after major surgery: a nutritional deficiency. Crit. Care Clin. 2010, 26:491-500. ix.
188. Zoppi S., Perez Nievas B.G., Madrigal J.L., Manzanares J., Leza J.C., Garcia-Bueno B. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 2011, 36:805-818.